Ríos-Tamayo, R. (2026). The Evolving Landscape of Anti-Clonal Therapy in Newly Diagnosed Systemic Light-Chain (AL) Amyloidosis: Evidence- and Time-Based Comparison with Multiple Myeloma. Life (2075-1729), 16(2), 363. https://doi.org/10.3390/life16020363
Chicago Style (17th ed.) CitationRíos-Tamayo, Rafael. "The Evolving Landscape of Anti-Clonal Therapy in Newly Diagnosed Systemic Light-Chain (AL) Amyloidosis: Evidence- and Time-Based Comparison with Multiple Myeloma." Life (2075-1729) 16, no. 2 (2026): 363. https://doi.org/10.3390/life16020363.
MLA (9th ed.) CitationRíos-Tamayo, Rafael. "The Evolving Landscape of Anti-Clonal Therapy in Newly Diagnosed Systemic Light-Chain (AL) Amyloidosis: Evidence- and Time-Based Comparison with Multiple Myeloma." Life (2075-1729), vol. 16, no. 2, 2026, p. 363, https://doi.org/10.3390/life16020363.